Cellectis S.A.
CMVLF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $135,850 | $170,468 | $94,739 | $363,492 |
| - Cash | $143,251 | $136,708 | $97,697 | $186,135 |
| + Debt | $91,461 | $85,056 | $75,771 | $100,871 |
| Enterprise Value | $84,060 | $118,816 | $72,813 | $278,228 |
| Revenue | $41,506 | $755 | $19,171 | $73,949 |
| % Growth | 5,397.5% | -96.1% | -74.1% | – |
| Gross Profit | $41,506 | $18 | $17,399 | $37,674 |
| % Margin | 100% | 2.4% | 90.8% | 50.9% |
| EBITDA | -$15,159 | -$92,636 | -$76,378 | -$83,147 |
| % Margin | -36.5% | -12,269.7% | -398.4% | -112.4% |
| Net Income | -$36,761 | -$103,174 | -$106,139 | -$81,074 |
| % Margin | -88.6% | -13,665.4% | -553.6% | -109.6% |
| EPS Diluted | -0.41 | -1.77 | -2.33 | -1.81 |
| % Growth | 76.8% | 24% | -28.7% | – |
| Operating Cash Flow | $22,989 | -$24,746 | -$87,444 | -$104,562 |
| Capital Expenditures | -$3,843 | -$1,073 | -$2,441 | -$19,743 |
| Free Cash Flow | $19,146 | -$25,819 | -$89,885 | -$124,305 |